Is Kombucha a Probiotic? What the Clinical Trials Actually Show

Kombucha contains live microorganisms, but it does not meet the scientific definition of a probiotic, and the human trial evidence for health benefits from plain kombucha is thin. ## Why it fails the strict definition A probiotic requires a **defined strain**, in an **adequate dose**, with a **demonstrated benefit** — see Probiotic: Why the Strict Definition Excludes Most Fermented Foods. Kombucha misses all three: - **Strain.** The microbial makeup varies by producer, by batch, and with fermentation time and conditions. A 2021 systematic review noted that production is not standardised and the final composition depends heavily on raw materials and process parameters, so kombuchas differ not only between producers but between batches from the same producer. - **Dose.** With composition unstandardised, no reliable count of any particular organism is delivered. - **Organisms.** The dominant residents are acetic acid bacteria and yeasts, not the intensively studied Lactobacillus and Bifidobacterium strains used in probiotic supplements and trials. See Lactobacillus: The Beneficial Bacteria Behind Fermented Foods and Gut Health. And many commercial kombuchas are **pasteurised**, which kills the live cultures entirely. The accurate description is a **fermented food containing live cultures** — the same category as unpasteurised sauerkraut or kimchi. ## What the human trials found **A controlled trial published in *Scientific Reports* (December 2024, UC San Diego).** Healthy participants on a Western diet consumed commercial kombucha daily for four weeks within an eight-week study. The result on health markers was null: no significant change in biochemical parameters or circulating inflammation markers across the cohort. Microbiome analysis did show a change — enrichment of Weizmannia, a kombucha-associated probiotic genus, and of other SCFA-producing microbes. See Weizmannia coagulans: The Spore-Forming Probiotic Formerly Called Bacillus coagulans. Two things about this trial matter. It was **small** — 16 in the kombucha arm and 8 controls — so it is a preliminary result rather than a definitive one. And it was **funded by a kombucha producer** and still reported null results on the primary health markers, which makes the modest microbiome finding more credible rather than less. **A 2025 Spanish randomised double-blind trial** (around 60 participants, six weeks) found more: reduced serum triglycerides, increased *Bifidobacterium*, and shifts in beta diversity. The crucial catch is that it tested **fibre-enriched** kombucha. The authors themselves frame the product as a synbiotic, meaning the effects are attributed to kombucha *plus* added inulin — and the fibre is doing much of the work. It is not evidence about ordinary kombucha. See Prebiotics, Probiotics, Synbiotics and Postbiotics: The Terminology. ## The honest summary Mayo Clinic's framing remains the fair one: a small amount of research suggests kombucha may offer benefits similar to probiotic supplements, but there are few valid medical studies of its role in human health. Practically: raw, unpasteurised kombucha plausibly adds some microbial diversity and live SCFA-producers to a diet, and as a low-sugar fermented drink it is a reasonable thing to enjoy. It is not a substitute for a characterised probiotic if you are targeting a specific effect. If you are buying it for live cultures, look for "raw" or "unpasteurised" and keep it refrigerated — that is the difference between live microbes and flavoured tea vinegar. Caveats from the literature: home-brewed batches carry contamination risk and, with certain glazed ceramic vessels, lead-leaching risk; and the drink contains trace alcohol, plus sugar and caffeine.